Circulating cytokines predict immune-related toxicity in melanoma patients receiving anti-PD-1-based immunotherapy.
Lim, Su Y; Lee, Jenny H; Gide, Tuba N; Menzies, Alexander M; Guminski, Alexander; Carlino, Matteo S; Breen, Edmond J; Yang, Jean Y H; Ghazanfar, Shila; Kefford, Richard F; Scolyer, Richard A; Long, Georgina V; Rizos, Helen.
Clin Cancer Res
; 2018 Nov 08.
Artigo em Inglês | MEDLINE | ID: mdl-30409824
Systemic treatments for metastatic cutaneous melanoma.
Autoimmune genetic risk variants as germline biomarkers of response to melanoma immune-checkpoint inhibition.
Paracrine release of IL-2 and anti-CTLA-4 enhances the ability of artificial polymer antigen-presenting cells to expand antigen-specific T cells and inhibit tumor growth in a mouse model.